论文部分内容阅读
对19例晚期肝癌伴门脉瘤柱的介入治疗疗效和肝动脉栓塞的安全性及疗效进行了回顾性分析。结果显示，13例经加用碘油或明胶海绵栓塞肝动脉的病例均有不同程度的肿瘤缩小，在抗癌药物加碘油、明胶海绵栓塞的肝动脉组中，9例门脉显影者仅1例ALT和AST升高，而3例门脉未显影者全部升高。作者认为：对伴有门脉癌栓的晚期肝癌，只要间接门静脉造影显示门静脉，应加用碘油和明胶海绵栓塞肝动脉；但对门脉未显影者，用碘油栓塞较为安全，不宜用明波海绵栓塞。应用该法治疗后，可延长患者的生存期。
The retrospective analysis was performed on the efficacy of interventional treatment and the safety and efficacy of hepatic artery embolization in 19 patients with advanced hepatocellular carcinoma and portal tumor. The results showed that 13 cases of embolization of hepatic artery with lipiodol or gelatin sponge all had tumor shrinkage to varying degrees. In the hepatic artery group with anti-cancer drug plus lipiodol and gelatin sponge embolization, 9 cases of portal arthroplasty were only found. One case had elevated ALT and AST, while all three portal arteries were not elevated. The author believes that: For advanced liver cancer with portal vein cancer thrombus, as long as the portal vein angiography shows the portal vein, should be added with lipiodol and gelatin sponge embolization of the hepatic artery; but for portal undeveloped persons, embolization with lipiodol is safer and should not be used Mingbo sponge embolism. After treatment with this method, the patient’s survival time can be prolonged.